Commit To Purchase Arcutis Biotherapeutics At $7.50, Earn 21.3% Using Options
Investors considering a purchase of Arcutis Biotherapeutics Inc (Symbol: ARQT) stock, but tentative about paying the going market price of $14.21/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2173588208-8c8f22f916ad46719d9aff854e35bd97.jpg "Should You Work at a Boutique Investment Bank?")
